13F-HR filed by Venrock Adviser, LLC
Venrock Adviser, LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:49:16 UTC, with 34 holding rows worth $2,058,215,412.
- Accession
- 0001615982-26-000019
- Filer
- CIK 1615982
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 34 entries on the cover page, a total value of $2,058,215,412 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,058,215,412 with VALUE read as dollars as filed, 13F file number 028-20281. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ORUKA THERAPEUTICS INC COM | 687604108 | Stock | 4,148,428 | $345,522,568 | dollars as filed | |
| ERASCA INC COM | 29479A108 | Stock | 20,089,932 | $294,518,403 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 2,485,448 | $221,279,435 | dollars as filed | |
| KORSANA BIOSCIENCES INC | 23255M303 | COMMON STOCK | 4,549,585 | $145,586,720 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 19,568,534 | $100,973,635 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 10,346,926 | $79,360,922 | dollars as filed | |
| DAMORA THERAPEUTICS INC | G2646Y104 | COMM STK | 3,603,595 | $76,684,502 | dollars as filed | |
| DIANTHUS THERAPEUTICS INC | 252828108 | COM | 822,020 | $72,378,861 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 3,257,917 | $67,080,511 | dollars as filed | |
| VOR BIOPHARMA INC | 929033207 | COMMON STOCK | 3,041,719 | $58,035,999 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 1,642,166 | $52,582,155 | dollars as filed | |
| Adlai Nortye | 00704R109 | SPONSORED ADS | 3,212,731 | $51,403,696 | dollars as filed | |
| JADE BIOSCIENCES INC | 008064206 | COM NEW | 3,220,364 | $45,246,114 | dollars as filed | |
| ACHIEVE LIFE SCIENCES INC | 004468500 | COMMON STOCK | 5,502,064 | $44,511,698 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 1,545,616 | $42,009,843 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 2,944,056 | $39,656,434 | dollars as filed | |
| DYNE THERAPEUTICS INC COM | 26818M108 | Stock | 2,173,913 | $35,021,738 | dollars as filed | |
| ADARx Pharmaceuticals, Inc. | 00654F105 | Common Stock, par value $0.0001 per share | 1,625,793 | $32,418,312 | dollars as filed | |
| CRESCENT BIOPHARMA INC | G2545C104 | COMMON STOCK | 2,133,734 | $31,131,179 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 7,445,050 | $28,067,839 | dollars as filed | |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 6,434,990 | $26,769,558 | dollars as filed | |
| X4 PHARMACEUTICALS INC | 98420X202 | COMMON STOCK | 7,644,072 | $22,167,809 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 1,379,965 | $21,182,463 | dollars as filed | |
| SURROZEN INC | 86889P208 | COMMON STOCK | 632,931 | $20,367,720 | dollars as filed | |
| PARABILIS MEDICINES INC COM | 698955101 | Stock | 625,000 | $20,181,250 | dollars as filed | |
| ARVINAS INC | 04335A105 | COM | 1,952,533 | $15,102,843 | dollars as filed | |
| CENTURY THERAPEUTICS INC | 15673T100 | COM | 8,695,652 | $14,869,565 | dollars as filed | |
| ENTERA BIO LTD | M40527109 | SHS | 5,106,337 | $14,859,441 | dollars as filed | |
| ARTIVA BIOTHERAPEUTICS INC | 04317A107 | COM | 2,043,596 | $14,550,404 | dollars as filed | |
| ALTO NEUROSCIENCE INC COM SHS | 02157Q109 | Stock | 500,000 | $12,765,000 | dollars as filed | |
| KORRO BIO INC | 500946108 | COMMON STOCK | 443,431 | $4,394,401 | dollars as filed | |
| TCGX ACQUISITION CORP | G8708J109 | COM | 300,000 | $3,753,000 | dollars as filed | |
| RESEARCH ALLIANCE CORP IV | G75228109 | CL A ORD SHS | 300,000 | $3,600,000 | dollars as filed | |
| INMED PHARMACEUTICALS INC | 457637700 | COM NEW | 133,378 | $181,394 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001615982-26-000019 | this filing | 2026-11-16 |